retatrutide benefits clinical trial retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide FDA Approval Status 2026:

Kennedy Jr., has criticized the reliance on the weight-loss drug Ozempic, raising concerns about government funding for it and advocating for addressing the root causes of obesity in America instead

Neither compound is FDA-approved for any clinical use

2400mg High-potency formulation for maximum antioxidant support Glutathione is the body's most abundant and important antioxidant, found in every cell

Individual data for all animals are given in the Appendix A

It has also been reported to alleviate concerns of the menopause, such as hot flushes

Vitamin B-Complex can also provide a calming effect which may reduce the symptoms of anxiety and depression